{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:07:56Z","timestamp":1794251276614,"version":"4.9.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007246","name":"Y\u00fcksek\u00f6\u011fretim Kurulu","doi-asserted-by":"publisher","award":["100\/2000"],"award-info":[{"award-number":["100\/2000"]}],"id":[{"id":"10.13039\/501100007246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.biopha.2025.118031","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T12:49:25Z","timestamp":1744289365000},"page":"118031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The role of thrombin in the paradoxical interplay of cancer metastasis and the vascular system: A driving dynamic"],"prefix":"10.1016","volume":"186","author":[{"given":"Ozge","family":"Bayrak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meltem","family":"Alper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Basbinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Bayrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2025.118031_bib1","first-page":"293","article-title":"Metastasis mechanisms","volume":"1796","author":"Geiger","year":"2009","journal-title":"Biochim Biophys. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2025.118031_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2005.05.028","article-title":"Tumor hypoxia and cancer progression","volume":"237","author":"Zhou","year":"2006","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.biopha.2025.118031_bib3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1248\/bpb.27.599","article-title":"Cancer anti-angiogenic therapy","volume":"27","author":"Shimizu","year":"2004","journal-title":"Biol. Pharm. Bull."},{"issue":"8","key":"10.1016\/j.biopha.2025.118031_bib4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastatic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2025.118031_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/path.1437","article-title":"Functional structure andmohamm composition of the extracellular matrix","volume":"200","author":"Bosman","year":"2003","journal-title":"J. Pathol."},{"issue":"3-4","key":"10.1016\/j.biopha.2025.118031_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.biochi.2004.10.025","article-title":"Tumor-stroma interactions: their role in the control of tumor cell invasion","volume":"87","author":"Zigrino","year":"2005","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.biopha.2025.118031_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","article-title":"Matrix metalloproteinases and tumor metastasis","volume":"25","author":"Deryugina","year":"2006","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"23","key":"10.1016\/j.biopha.2025.118031_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399403006628","article-title":"Metalloproteinases and their inhibitors in angiogenesis","volume":"5","author":"Lafleur","year":"2003","journal-title":"Expert Rev. Mol. Med"},{"issue":"1","key":"10.1016\/j.biopha.2025.118031_bib9","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022194","article-title":"\u201cTGF-\u03b2 family signaling in epithelial differentiation and epithelial-mesenchymal transition\u201d","volume":"10","author":"Kahata","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118031_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/CCO.0b013e32835b6371","article-title":"\u201cTGF-\u03b2 signaling and epithelial-mesenchymal transition in cancer progression\u201d","volume":"25","author":"Katsuno","year":"2013","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.biopha.2025.118031_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.5604\/17322693.1148710","article-title":"Breast cancer metastasis - insight into selected molecular mechanisms of the phenomenon","volume":"69","author":"Koz\u0142owski","year":"2015","journal-title":"Post. Hig. Med Dosw"},{"issue":"12","key":"10.1016\/j.biopha.2025.118031_bib12","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","article-title":"Anoikis molecular pathways and its role in cancer progression","volume":"1833","author":"Paoli","year":"2013","journal-title":"Biochim Biophys. Acta"},{"issue":"2","key":"10.1016\/j.biopha.2025.118031_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biopha.2025.118031_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat. Rev. Can."},{"issue":"3","key":"10.1016\/j.biopha.2025.118031_bib15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbamcr.2015.07.008","article-title":"The role of platelets in the tumor microenvironment: From solid tumors to leukemia","volume":"1863","author":"Yan","year":"2016","journal-title":"Biochim Biophys. Acta"},{"issue":"2","key":"10.1016\/j.biopha.2025.118031_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2009.06.018","article-title":"CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages","volume":"16","author":"DeNardo","year":"2009","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.biopha.2025.118031_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12943-018-0937-3","article-title":"The functional role of integrins during intra- and extravasation within the metastatic cascade","volume":"18","author":"S\u00f6keland","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2025.118031_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1478-811X-6-10","article-title":"Extravasation of leukocytes in comparison to tumor cells","volume":"6","author":"Strell","year":"2008","journal-title":"Cell Commun. Signal"},{"issue":"9","key":"10.1016\/j.biopha.2025.118031_bib19","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1055\/s-0039-1692721","article-title":"Linking complement activation, coagulation, and neutrophils in transplant-associated thrombotic microangiopathy","volume":"119","author":"Gavriilaki","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.biopha.2025.118031_bib20","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3346\/jkms.2015.30.9.1213","article-title":"Endothelial dysfunction: clinical implications in cardiovascular disease and therapeutic approaches","volume":"30","author":"Park","year":"2015","journal-title":"J. Korean Med. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2025.118031_bib21","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/hc0502.104540","article-title":"\u2018\u2018Fundamentals of endothelial function for the clinical cardiologist\u2019","volume":"105","author":"Verma","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biopha.2025.118031_bib22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0735-1097(99)00259-4","article-title":"Assessment and treatment of endothelial dysfunction in humans","volume":"34","author":"Anderson","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118031_bib23","first-page":"369","article-title":"\u2018\u2019Blood coagulation.\u2019\u2019 Best practice & research","volume":"17","author":"Norris","year":"2003","journal-title":"Clin. Obstet. Gynaecol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118031_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/snuc.2001.21406","article-title":"Pathophysiology and diagnosis of deep venous thrombosis","volume":"31","author":"Line","year":"2001","journal-title":"Semin. Nucl. Med."},{"issue":"9215","key":"10.1016\/j.biopha.2025.118031_bib25","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)02225-X","article-title":"Blood coagulation","volume":"355","author":"Dahlb\u00e4ck","year":"2000","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.biopha.2025.118031_bib26","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1177\/0091270007302952","article-title":"Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity","volume":"47","author":"Graff","year":"2007","journal-title":"J. Clin. Pharm."},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118031_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0049-3848(02)00210-4","article-title":"Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate","volume":"107","author":"Macchi","year":"2002","journal-title":"Thromb. Res"},{"issue":"11","key":"10.1016\/j.biopha.2025.118031_bib28","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.3390\/cancers16112082","article-title":"Cancer-associated thrombosis: pathophysiology, laboratory assessment, and current guidelines","volume":"16","author":"Tsantes","year":"2024","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.biopha.2025.118031_bib29","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.31557\/APJCP.2021.22.11.3601","article-title":"Efficacy of rivaroxaban use in solid tumour malignancy: experience from a tertiary care cancer centre","volume":"22","author":"Ahmat","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"6","key":"10.1016\/j.biopha.2025.118031_bib30","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/ATVBAHA.123.318779","article-title":"Updates in the incidence, pathogenesis, and management of cancer and venous thromboembolism","volume":"43","author":"Girardi","year":"2023","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118031_bib31","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0889-8588(05)70349-X","article-title":"\u201cHypercoagulability in cancer\u201d","volume":"10","author":"Green","year":"1996","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"4","key":"10.1016\/j.biopha.2025.118031_bib32","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0002-8703(96)90321-X","article-title":"Cancer and venous thromboembolism","volume":"132","author":"Piccioli","year":"1996","journal-title":"Am. Heart J."},{"issue":"2","key":"10.1016\/j.biopha.2025.118031_bib33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-2008-1079255","article-title":"Mechanisms linking tumor cell-associated procoagulant function to tumor dissemination","volume":"34","author":"Palumbo","year":"2008","journal-title":"Semin Thromb. Hemost."},{"issue":"1","key":"10.1016\/j.biopha.2025.118031_bib34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1055\/s-2006-933337","article-title":"Emerging insights in tissue factor-dependent signaling events","volume":"32","author":"Versteeg","year":"2006","journal-title":"Semin Thromb. Hemost."},{"key":"10.1016\/j.biopha.2025.118031_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115027","article-title":"The role of coagulome in the tumor immune microenvironment","volume":"200","author":"Wahab","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2025.118031_bib36","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nm1037","article-title":"Regulation of angiogenesis by tissue factor cytoplasmic domain signaling","volume":"10","author":"Belting","year":"2004","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.biopha.2025.118031_bib37","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1074\/jbc.M704855200","article-title":"Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and beta1-integrin on the cell surface","volume":"283","author":"Radjabi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118031_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2119\/molmed.2016.00214","article-title":"Dabigatran potentiates gemcitabine-induced growth inhibition of pancreatic cancer in mice","volume":"23","author":"Shi","year":"2017","journal-title":"Mol. Med"},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118031_bib39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.18632\/oncotarget.211","article-title":"The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic target","volume":"2","author":"Villares","year":"2011","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.biopha.2025.118031_bib40","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1111\/bph.15384","article-title":"A novel oncotherapy strategy: direct thrombin inhibitors suppress progression, dissemination and spontaneous metastasis in non-small cell lung cancer","volume":"179","author":"Zhao","year":"2022","journal-title":"Br. J. Pharm."},{"issue":"63","key":"10.1016\/j.biopha.2025.118031_bib41","doi-asserted-by":"crossref","first-page":"107334","DOI":"10.18632\/oncotarget.21015","article-title":"Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118031_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119499","article-title":"Interplay between MAPK\/ERK signaling pathway and MicroRNAs: a crucial mechanism regulating cancer cell metabolism and tumor progression","volume":"278","author":"Asl","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118031_bib43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41392-020-00366-6","article-title":"Thrombin-mediated vasculogenic mimicry: important lessons to improve anticoagulant therapy of selected cancer patients","volume":"5","author":"Spek","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"issue":"19","key":"10.1016\/j.biopha.2025.118031_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38831","article-title":"Blood hypercoagulability and thrombosis mechanisms in cancer patients -A brief review","volume":"10","author":"Peng","year":"2024","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.biopha.2025.118031_bib45","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1055\/s-0043-1776875","article-title":"The complex role of thrombin in cancer and metastasis: focus on interactions with the immune system","volume":"50","author":"Aleksandrowicz","year":"2024","journal-title":"Semin. Thromb. Hemost."},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118031_bib46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000046587","article-title":"The thrombophilic state in cancer patients","volume":"106","author":"Gouin-Thibault","year":"2001","journal-title":"Acta Haematol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118031_bib47","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1161\/01.ATV.20.12.2511","article-title":"Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway","volume":"20","author":"Bajzar","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118031_bib48","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1365-2141.2000.01890.x","article-title":"Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia","volume":"108","author":"Meijers","year":"2000","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118031_bib49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMp030086","article-title":"Cancer-associated thrombosis","volume":"349","author":"Bick","year":"2003","journal-title":"N. Engl. J. Med"},{"issue":"5","key":"10.1016\/j.biopha.2025.118031_bib50","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1538-7836.2004.00682.x","article-title":"Tumor growth and metastasis are not affected in thrombin-activatable fibrinolysis inhibitor-deficient mice","volume":"2","author":"Reijerkerk","year":"2004","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.biopha.2025.118031_bib51","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0049-3848(00)00294-2","article-title":"\u201cCisplatin triggers platelet activation\u201d","volume":"99","author":"Togna","year":"2000","journal-title":"Thromb. Res"},{"issue":"16","key":"10.1016\/j.biopha.2025.118031_bib52","doi-asserted-by":"crossref","first-page":"17184","DOI":"10.1002\/cam4.6332","article-title":"The effects of coagulation factors and their inhibitors on proliferation and migration in colorectal cancer","volume":"12","author":"Rees","year":"2023","journal-title":"Cancer Med"},{"issue":"10","key":"10.1016\/j.biopha.2025.118031_bib53","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4161\/cbt.10.10.13236","article-title":"Use of dabigatran etexilate to reduce breast cancer progression","volume":"10","author":"DeFeo","year":"2010","journal-title":"Cancer Biol. Ther."},{"issue":"12","key":"10.1016\/j.biopha.2025.118031_bib54","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1080\/15384047.2015.1078025","article-title":"Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasis","volume":"16","author":"Alexander","year":"2015","journal-title":"Cancer Biol. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2025.118031_bib55","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/jth.14443","article-title":"The direct oral anticoagulants rivaroxaban and dabigatran do not inhibit orthotopic growth and metastasis of human breast cancer in mice","volume":"17","author":"Buijs","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.biopha.2025.118031_bib56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2119\/molmed.2016.00214","article-title":"Dabigatran potentiates gemcitabine-induced growth inhibition of pancreatic cancer in mice","volume":"23","author":"Shi","year":"2017","journal-title":"Mol. Med"},{"issue":"6","key":"10.1016\/j.biopha.2025.118031_bib57","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/j.thromres.2010.02.018","article-title":"Coagulation Factor Xa inhibits cancer cell migration via LIMK1-mediated cofilin inactivation","volume":"125","author":"Borensztajn","year":"2010","journal-title":"Thromb. Res"},{"issue":"2","key":"10.1016\/j.biopha.2025.118031_bib58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.thromres.2009.01.015","article-title":"Coagulation factor Xa inhibits cancer cell migration via protease-activated receptor-1 activation","volume":"124","author":"Borensztajn","year":"2009","journal-title":"Thromb. Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118031_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77963-6","article-title":"Activation of PAR2 by tissue factor induces the release of the PTEN from MAGI proteins and regulates PTEN and Akt activities","volume":"10","author":"Mohammad","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2025.118031_bib60","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3390\/cancers11081103","article-title":"Coagulation factor Xa promotes solid tumor growth, experimental metastasis and endothelial cell activation","volume":"11","author":"Arce","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.biopha.2025.118031_bib61","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1186\/s13063-020-04675-7","article-title":"Rivaroxaban compared to no treatment in ER-negative stage I-III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial","volume":"21","author":"Castle","year":"2020","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.biopha.2025.118031_bib62","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/cancers11010100","article-title":"Thrombin generation and cancer: contributors and consequences","volume":"11","author":"Reddel","year":"2019","journal-title":"Cancers"},{"issue":"164","key":"10.1016\/j.biopha.2025.118031_bib63","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0004-2022","article-title":"Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancer","volume":"31","author":"Otten","year":"2022","journal-title":"Eur. Respir. Rev.: Off. J. Eur. Respir. Soc."},{"issue":"2","key":"10.1016\/j.biopha.2025.118031_bib64","article-title":"Use of new oral anticoagulants \/ direct oral anticoagulants in malignant patients","volume":"12","author":"Khan","year":"2020","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.biopha.2025.118031_bib65","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/cancers11010046","article-title":"Direct oral anticoagulant drugs: on the treatment of cancer-related venous thromboembolism and their potential anti-neoplastic effect","volume":"11","author":"Grandoni","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.biopha.2025.118031_bib66","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3390\/biology11040596","article-title":"Commonly prescribed anticoagulants exert anticancer effects in oral squamous cell carcinoma cells in vitro","volume":"11","author":"Ling","year":"2022","journal-title":"Biology"},{"issue":"20","key":"10.1016\/j.biopha.2025.118031_bib67","doi-asserted-by":"crossref","first-page":"10421","DOI":"10.1016\/S0021-9258(19)86724-8","article-title":"The binding of thrombin by fibrin","volume":"254","author":"Liu","year":"1979","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118031_bib68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.thromres.2014.11.012","article-title":"Tranexamic acid--an old drug still going strong and making a revival","volume":"135","author":"Tengborn","year":"2015","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118031_bib69","first-page":"411","article-title":"Effect of tranexamic acid on the growth and metastasis of V2 carcinoma in rabbits","volume":"72","author":"Kodama","year":"1981","journal-title":"Gan"},{"issue":"5","key":"10.1016\/j.biopha.2025.118031_bib70","first-page":"295","article-title":"Influence of tranexamic acid on tumour vascularization. An experimental microangiographic study","volume":"1","author":"Sundbeck","year":"1981","journal-title":"Anticancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2025.118031_bib71","first-page":"339","article-title":"Effect of antifibrinolysis treatment on human cancer in nude mice","volume":"2","author":"Ogawa","year":"1982","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2025.118031_bib72","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0090-8258(86)90026-0","article-title":"The inhibitory effect of tranexamic acid on human ovarian carcinoma cell grown in vitro and in vivo","volume":"24","author":"Kikuchi","year":"1986","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118031_bib73","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/00016348609157383","article-title":"Adjuvant effects of tranexamic acid to chemotherapy in ovarian cancer patients with large amount of ascites","volume":"65","author":"Kikuchi","year":"1986","journal-title":"Acta Obstet. Et. Gynecol. Scand."},{"issue":"2","key":"10.1016\/j.biopha.2025.118031_bib74","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tox.2009.06.004","article-title":"Tranexamic acid protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells","volume":"262","author":"Kim","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.biopha.2025.118031_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.792600","article-title":"Repurposing tranexamic acid as an anticancer agent","volume":"12","author":"Law","year":"2022","journal-title":"Front Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2025.118031_bib76","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1601-0825.2008.01507.x","article-title":"Tranexamic acid can inhibit tongue squamous cell carcinoma invasionin vitro","volume":"15","author":"Suojanen","year":"2009","journal-title":"Oral. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2025.118031_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003601","article-title":"Tranexamic acid and bleeding in patients treated with non-vitamin K oral anticoagulants undergoing dental extraction: the Extract-NOAC randomized clinical trial","volume":"18","author":"Ockerman","year":"2021","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.biopha.2025.118031_bib78","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.21037\/gs.2018.03.10","article-title":"The use of tranexamic acid in microsurgery-is it safe?","volume":"7","author":"Lardi","year":"2018","journal-title":"Gland Surg."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:54:11Z","timestamp":1781823251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225002252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":78,"alternative-id":["S0753332225002252"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118031","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of thrombin in the paradoxical interplay of cancer metastasis and the vascular system: A driving dynamic","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118031"}}